ImmuSmol Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $649K
Latest Deal Amount
  • Investors
  • 2

ImmuSmol General Information


Developer of small molecule antibodies intended to block the mechanisms used by tumors to escape the surveillance of the immune system. The company's antibodies are used in the research, diagnostic and therapeutic applications, enabling healthcare professionals in visualization, quantification and modulation of monoclonal antibodies interfering with endogenous small molecules involved in cancer and CNS disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • PTIB - Hôpital Xavier Arnozan
  • Avenue Haut Lévêque
  • 33600 Pessac
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuSmol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 23-Sep-2014 $649K 00000 Completed Generating Revenue
1. Accelerator/Incubator 29-Jul-2014 00000 00000 Completed Generating Revenue
To view ImmuSmol’s complete valuation and funding history, request access »

ImmuSmol Executive Team (2)

Name Title Board Seat Contact Info
Alban Bessede Ph.D Founder & Chief Executive Officer
Loic Cerf Chief Operating Officer
To view ImmuSmol’s complete executive team members history, request access »

ImmuSmol Board Members (1)

Name Representing Role Since
Vincent Picq ImmuSmol Board Member 000 0000
To view ImmuSmol’s complete board members history, request access »

ImmuSmol Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmuSmol Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Incubateur Régional d'Aquitaine Accelerator/Incubator Minority 000 0000 000000 0
To view ImmuSmol’s complete investors history, request access »